MEDFOAM - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
85286134
Word Mark
MEDFOAM
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2014-01-20
Filing Date
2011-04-05
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2013-04-23
Attorney Name
Law Office Assigned Location Code
L90
Employee Name
COLLIER, DAVID E
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Antibacterial pharmaceuticals; Astringents; Balms for pharmaceutical purposes; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for dermal and/or mucosal absorption that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti- infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Veterinary pharmaceutical compounds for equine use to treat conditions of the leg, hoof, ear, nose and throat; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes
Goods and Services
Medical apparatus for introducing pharmaceutical preparations into the human body
Goods and Services
Research and development in the pharmaceutical and biotechnology fields
Goods and Services
Dispensing of pharmaceuticals
Pseudo Mark
MED FOAM
Classification Information
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2011-04-08
Primary Code
010
Correspondences
Name
Robert L Marsh
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2011-04-08 | NEW APPLICATION ENTERED IN TRAM |
2011-04-08 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2011-04-09 | NOTICE OF PSEUDO MARK MAILED |
2011-07-05 | ASSIGNED TO EXAMINER |
2011-07-14 | NON-FINAL ACTION WRITTEN |
2011-07-14 | NON-FINAL ACTION E-MAILED |
2011-07-14 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2011-12-13 | TEAS REVOKE/APPOINT ATTORNEY RECEIVED |
2011-12-13 | ATTORNEY REVOKED AND/OR APPOINTED |
2011-12-29 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2011-12-29 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2011-12-29 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2012-01-24 | SUSPENSION LETTER WRITTEN |
2012-01-24 | LETTER OF SUSPENSION E-MAILED |
2012-01-24 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
2012-07-24 | ASSIGNED TO LIE |
2012-07-26 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
2012-08-16 | NON-FINAL ACTION WRITTEN |
2012-08-16 | NON-FINAL ACTION E-MAILED |
2012-08-16 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2013-03-14 | EXAMINERS AMENDMENT -WRITTEN |
2013-03-14 | EXAMINERS AMENDMENT E-MAILED |
2013-03-14 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2013-03-14 | EXAMINER'S AMENDMENT ENTERED |
2013-03-14 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2013-03-19 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2013-04-03 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2013-04-23 | PUBLISHED FOR OPPOSITION |
2013-04-23 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2013-06-18 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2014-01-20 | ABANDONMENT - NO USE STATEMENT FILED |
2014-01-21 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |